First Patient Enrolled in ECOG-ACRIN Phase III Trial of Syndax’s Entinostat
30 June 2014
The ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals Inc. announced today enrollment of the first patient in E2112, a randomized phase III clinical trial of Syndax’s histone deacetylase (HDAC) inhibitor, entinostat, for the treatment of patients with advanced breast cancer. The trial is evaluating whether the addition of entinostat to endocrine therapy (exemestane, a steroidal aromatase inhibitor) improves progression-free survival and/or overall survival in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative advanced breast cancer who have progressed following treatment with a non-steroidal aromatase inhibitor.
Overcoming Clinical Challenges in BRIC Markets
20 June 2014
Rapidly changing markets raise potential for clinical trials in BRIC nations, despite challenges
10 June 2014
NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced that it has acquired the rights, in four separate transactions, to three well-studied Candida vaccine antigens, significantly bolstering the Company’s Candida vaccine pipeline.
FDA Issues Guidance on Expedited Programs for Serious Conditions
30 May 2014
FDA has finalized guidance on expedited programs for drugs and biologics to treat serious conditions. The guidance, released May 29, 2014, details four programs that the agency has designed to facilitate and expedite development and review of new drugs for the treatment of life-threatening conditions.
Report:Positive Outlook for Investment in Global Pharma and Biotech Industry
30 May 2014
New analysis from Frost & Sullivan’s Private Equity and Venture Capital Investment reveals the total number of private equity and venture capital (PEVC) deals in the pharmaceutical and biotechnology industry decreased from 1063 in 2010 to 480 in 2013. However, while the returns from the pharmaceutical and biotechnology industry have been dwindling, they are better compared to the performance of other industries, the report finds.
Improving the efficiency of health care will free up about 140-150 billion rubles
30 May 2014
Optimization of Health will release a significant amount of money , said the Minister of Health Veronika Skvortsova . At the current level of system performance by 2016 there may be some difficulties. However, if it significantly increase , the resource can be released about 140-150 billion rubles.
U.S.-Russia Innovation Corridor Selects Participants for Spring 2014
30 May 2014
Following a Competitive Selection Process, American Councils Announces Spring 2014 Residents in IT, biotechnology, and advanced manufacturing.
30 May 2014
The Intellectual Property & Science business of Thomson Reuters, the world leader in providing intelligent information to businesses and professionals, today announced the release of Overcoming Clinical Challenges in BRIC Markets, a report exploring the benefits and challenges of conducting clinical trials in the pharmaceutical markets of the BRIC nations: Brazil, Russia, India and China.
23.7 billion rubles to 11,175 skilled care for people suffering from rare diseases
27 May 2014
Medvedev Instructs to Submit Proposals for Public Funding of Nuclear and Biomedicine
24 May 2014
Russian Prime Minister Dmitry Medvedev has charged the Ministries of Health, Industry, Economic Development and Finance, in conjunction with development institutions, with submitting proposals to the government for public funding of measures to support the development of nuclear medicine and biomedical technologies in 2015-2017, according to a statement on the website of the Cabinet.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025
Russia Begins Production of Terbium-161 Isotope for Cancer Therapy
10 January 2025
FMBA has begun clinical trials of a vaccine against five serotypes of meningococcus
10 January 2025